(Q40630247)

English

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

scientific article published on September 1999

Statements

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease (English)
M A Cobleigh
C L Vogel
D Tripathy
N J Robert
S Scholl
L Fehrenbacher
J M Wolter
V Paton
G Lieberman
D J Slamon
1 September 1999
2639-2648

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit